Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of MXN 4.76 trillion. The enterprise value is 5.19 trillion.
| Market Cap | 4.76T |
| Enterprise Value | 5.19T |
Important Dates
The next estimated earnings date is Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Sep 15, 2025 |
Share Statistics
| Current Share Class | 2.48B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.91% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 79.22% |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 13.64 and the forward PE ratio is 11.62.
| PE Ratio | 13.64 |
| Forward PE | 11.62 |
| PS Ratio | 4.04 |
| PB Ratio | 5.00 |
| P/TBV Ratio | 17.37 |
| P/FCF Ratio | 19.90 |
| P/OCF Ratio | 15.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 21.68.
| EV / Earnings | 14.86 |
| EV / Sales | 4.41 |
| EV / EBITDA | 8.89 |
| EV / EBIT | 10.42 |
| EV / FCF | 21.68 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.
| Current Ratio | 1.66 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 1.30 |
| Debt / FCF | 3.17 |
| Interest Coverage | 21.34 |
Financial Efficiency
Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 19.31%.
| Return on Equity (ROE) | 39.49% |
| Return on Assets (ROA) | 13.76% |
| Return on Invested Capital (ROIC) | 19.31% |
| Return on Capital Employed (ROCE) | 26.94% |
| Revenue Per Employee | 15.92M |
| Profits Per Employee | 4.72M |
| Employee Count | 75,000 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, Merck & Co. has paid 50.84 billion in taxes.
| Income Tax | 50.84B |
| Effective Tax Rate | 12.71% |
Stock Price Statistics
The stock price has decreased by -9.36% in the last 52 weeks. The beta is 0.32, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -9.36% |
| 50-Day Moving Average | 1,628.11 |
| 200-Day Moving Average | 1,616.55 |
| Relative Strength Index (RSI) | 75.68 |
| Average Volume (20 Days) | 6,104 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.11 |
Income Statement
In the last 12 months, Merck & Co. had revenue of MXN 1.18 trillion and earned 349.13 billion in profits. Earnings per share was 138.59.
| Revenue | 1.18T |
| Gross Profit | 917.26B |
| Operating Income | 498.71B |
| Pretax Income | 400.17B |
| Net Income | 349.13B |
| EBITDA | 578.20B |
| EBIT | 498.71B |
| Earnings Per Share (EPS) | 138.59 |
Balance Sheet
The company has 334.08 billion in cash and 758.89 billion in debt, giving a net cash position of -424.81 billion.
| Cash & Cash Equivalents | 334.08B |
| Total Debt | 758.89B |
| Net Cash | -424.81B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 952.09B |
| Book Value Per Share | 382.35 |
| Working Capital | 347.20B |
Cash Flow
In the last 12 months, operating cash flow was 313.01 billion and capital expenditures -73.66 billion, giving a free cash flow of 239.35 billion.
| Operating Cash Flow | 313.01B |
| Capital Expenditures | -73.66B |
| Free Cash Flow | 239.35B |
| FCF Per Share | n/a |
Margins
Gross margin is 77.85%, with operating and profit margins of 42.33% and 29.63%.
| Gross Margin | 77.85% |
| Operating Margin | 42.33% |
| Pretax Margin | 33.96% |
| Profit Margin | 29.63% |
| EBITDA Margin | 49.07% |
| EBIT Margin | 42.33% |
| FCF Margin | 20.31% |
Dividends & Yields
This stock pays an annual dividend of 62.69, which amounts to a dividend yield of 3.27%.
| Dividend Per Share | 62.69 |
| Dividend Yield | 3.27% |
| Dividend Growth (YoY) | 13.30% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 42.60% |
| Buyback Yield | 0.91% |
| Shareholder Yield | 4.18% |
| Earnings Yield | 7.33% |
| FCF Yield | 5.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 3.89 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.89 |
| Piotroski F-Score | 5 |